264 related articles for article (PubMed ID: 33132928)
1. New Insights on the Effects of Methylphenidate in Attention Deficit Hyperactivity Disorder.
Pitzianti MB; Spiridigliozzi S; Bartolucci E; Esposito S; Pasini A
Front Psychiatry; 2020; 11():531092. PubMed ID: 33132928
[TBL] [Abstract][Full Text] [Related]
2. Low dopamine transporter occupancy by methylphenidate as a possible reason for reduced treatment effectiveness in ADHD patients with cocaine dependence.
Crunelle CL; van den Brink W; Veltman DJ; van Emmerik-van Oortmerssen K; Dom G; Schoevers RA; Booij J
Eur Neuropsychopharmacol; 2013 Dec; 23(12):1714-23. PubMed ID: 23731497
[TBL] [Abstract][Full Text] [Related]
3. Association analysis of norepinephrine transporter polymorphisms and methylphenidate response in ADHD patients.
Angyal N; Horvath EZ; Tarnok Z; Richman MJ; Bognar E; Lakatos K; Sasvari-Szekely M; Nemoda Z
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt A):122-128. PubMed ID: 29374517
[TBL] [Abstract][Full Text] [Related]
4. The Decrease in Human Endogenous Retrovirus-H Activity Runs in Parallel with Improvement in ADHD Symptoms in Patients Undergoing Methylphenidate Therapy.
Cipriani C; Pitzianti MB; Matteucci C; D'Agati E; Miele MT; Rapaccini V; Grelli S; Curatolo P; Sinibaldi-Vallebona P; Pasini A; Balestrieri E
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30360480
[TBL] [Abstract][Full Text] [Related]
5. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
Cheon KA; Ryu YH; Kim JW; Cho DY
Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
[TBL] [Abstract][Full Text] [Related]
6. Methylphenidate DAT binding in adolescents with Attention-Deficit/ Hyperactivity Disorder comorbid with Substance Use Disorder--a single photon emission computed tomography with [Tc(99m)]TRODAT-1 study.
Szobot CM; Shih MC; Schaefer T; Júnior N; Hoexter MQ; Fu YK; Pechansky F; Bressan RA; Rohde LA
Neuroimage; 2008 Apr; 40(3):1195-201. PubMed ID: 18282769
[TBL] [Abstract][Full Text] [Related]
7. Chronic methylphenidate preferentially alters catecholamine protein targets in the parietal cortex and ventral striatum.
Quansah E; Zetterström TSC
Neurochem Int; 2019 Mar; 124():193-199. PubMed ID: 30660754
[TBL] [Abstract][Full Text] [Related]
8. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
[TBL] [Abstract][Full Text] [Related]
9. Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: a longitudinal open label trial.
Pasini A; Sinibaldi L; Paloscia C; Douzgou S; Pitzianti MB; Romeo E; Curatolo P; Pizzuti A
Eur J Paediatr Neurol; 2013 Jul; 17(4):407-14. PubMed ID: 23541676
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
[TBL] [Abstract][Full Text] [Related]
11. Randomized, Double-Blind, Placebo-Controlled Acute Comparator Trials of Lisdexamfetamine and Extended-Release Methylphenidate in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Newcorn JH; Nagy P; Childress AC; Frick G; Yan B; Pliszka S
CNS Drugs; 2017 Nov; 31(11):999-1014. PubMed ID: 28980198
[TBL] [Abstract][Full Text] [Related]
12. Manganese in children with attention-deficit/hyperactivity disorder: relationship with methylphenidate exposure.
Farias AC; Cunha A; Benko CR; McCracken JT; Costa MT; Farias LG; Cordeiro ML
J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):113-8. PubMed ID: 20415606
[TBL] [Abstract][Full Text] [Related]
13. Acute neuropsychological effects of methylphenidate in stimulant drug-naïve boys with ADHD II--broader executive and non-executive domains.
Rhodes SM; Coghill DR; Matthews K
J Child Psychol Psychiatry; 2006 Nov; 47(11):1184-94. PubMed ID: 17076758
[TBL] [Abstract][Full Text] [Related]
14. Effects of methylphenidate on multiple components of attention in children with attention deficit hyperactivity disorder.
Tucha O; Prell S; Mecklinger L; Bormann-Kischkel C; Kübber S; Linder M; Walitza S; Lange KW
Psychopharmacology (Berl); 2006 Apr; 185(3):315-26. PubMed ID: 16521033
[TBL] [Abstract][Full Text] [Related]
15. Value of 99mTc-TRODAT-1 SPECT to predict clinical response to methylphenidate treatment in adults with attention deficit hyperactivity disorder.
la Fougère C; Krause J; Krause KH; Josef Gildehaus F; Hacker M; Koch W; Hahn K; Tatsch K; Dresel S
Nucl Med Commun; 2006 Sep; 27(9):733-7. PubMed ID: 16894328
[TBL] [Abstract][Full Text] [Related]
16. Effects of Methylphenidate on the Dopamine Transporter and Beyond.
Zetterström TSC; Quansah E; Grootveld M
Curr Top Behav Neurosci; 2022; 57():127-157. PubMed ID: 35507284
[TBL] [Abstract][Full Text] [Related]
17. Responsivity of the Striatal Dopamine System to Methylphenidate-A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Aster HC; Romanos M; Walitza S; Gerlach M; Mühlberger A; Rizzo A; Andreatta M; Hasenauer N; Hartrampf PE; Nerlich K; Reiners C; Lorenz R; Buck AK; Deserno L
Front Psychiatry; 2022; 13():804730. PubMed ID: 35492708
[TBL] [Abstract][Full Text] [Related]
18. Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths.
Leddy JJ; Waxmonsky JG; Salis RJ; Paluch RA; Gnagy EM; Mahaney P; Erbe R; Pelham WE; Epstein LH
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):127-36. PubMed ID: 19364291
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate administration reverts attentional inflexibility in adolescent rats submitted to a model of neonatal hypoxia-ischemia: Predictive validity for ADHD study.
Miguel PM; Deniz BF; Confortim HD; Bronauth LP; de Oliveira BC; Alves MB; Silveira PP; Pereira LO
Exp Neurol; 2019 May; 315():88-99. PubMed ID: 30771298
[TBL] [Abstract][Full Text] [Related]
20. Effects of methylphenidate on body index and physical fitness in Korean children with attention deficit hyperactivity disorder.
Kang KD; Yun SW; Chung U; Kim TH; Park JH; Park IH; Han DH
Hum Psychopharmacol; 2016 Mar; 31(2):76-82. PubMed ID: 26756111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
